Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function
<strong>Background</strong> The capsular group B meningococcal vaccine (4CMenB) is recommended for children with complement deficiencies, asplenia and splenic dysfunction, however, data on the immunogenicity of 4CMenB in these ‘at-risk’ children are missing. <strong>Methods</st...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Academy of Pediatrics
2018
|